{
    "clinical_study": {
        "@rank": "14852", 
        "arm_group": {
            "arm_group_label": "Diagnostic (light-scattering spectroscopy)", 
            "arm_group_type": "Experimental", 
            "description": "Patients undergo light-scattering spectroscopy of the breast in addition to standard of care as it relates to screening for breast cancer or treatment of breast cancer."
        }, 
        "brief_summary": {
            "textblock": "This pilot clinical trial studies light-scattering spectroscopy in finding disease in\n      patients with stage II-III breast cancer. Diagnostic procedures, such as light-scattering\n      spectroscopy, may help find and diagnose breast cancer"
        }, 
        "brief_title": "Light-Scattering Spectroscopy for Detection of Breast Cancer", 
        "completion_date": {
            "#text": "November 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Healthy, no Evidence of Disease", 
            "Stage II Breast Cancer", 
            "Stage IIIA Breast Cancer", 
            "Stage IIIB Breast Cancer", 
            "Stage IIIC Breast Cancer"
        ], 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "PRIMARY OBJECTIVES: I. To evaluate whether light-scattering spectroscopy can reliably\n      distinguish between two subject groups: those with clinical stage II or stage III breast\n      cancer and those without breast cancer.\n\n      OUTLINE:  Patients undergo light-scattering spectroscopy of the breast in addition to\n      standard of care as it relates to screening for breast cancer or treatment of breast cancer."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Participants who are breast cancer free (mammogram \"negative\" within 1 month of\n             testing) with the absence of clinical suspicion of breast cancer on physical exam or\n             with clinical stage II or stage III breast cancer. PLEASE NOTE: Recruitment for this\n             study is only limited to patients who are scheduled for a mammogram at USC. There is\n             no compensation to participants.\n\n          -  Provision of informed consent prior to any study-related procedures\n\n        Exclusion Criteria:\n\n          -  Females with tattoos on either or both breasts\n\n          -  Females with nipple piercings on either or both breasts\n\n          -  Females with skin piercings (aka microdermal anchor surface or microdermal piercings)\n             in either or both breasts\n\n          -  Females unable to provide informed consent\n\n          -  Females s/p treatment for breast cancer"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "110", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 18, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01755208", 
            "org_study_id": "1B-12-6", 
            "secondary_id": "NCI-2012-02769"
        }, 
        "intervention": {
            "arm_group_label": "Diagnostic (light-scattering spectroscopy)", 
            "description": "Undergo light-scattering spectroscopy", 
            "intervention_name": "light-scattering spectroscopy", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "April 29, 2014", 
        "location": {
            "contact": {
                "email": "victoria.soto@med.usc.edu", 
                "last_name": "Victoria Soto", 
                "phone": "323-226-6384"
            }, 
            "facility": {
                "address": {
                    "city": "Los Angeles", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "90033"
                }, 
                "name": "USC Norris Comprehensive Cancer Center"
            }, 
            "investigator": {
                "last_name": "Jacques Van Dam", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Light-Scattering Spectroscopy for the Detection of Stage II-III Breast Cancer: A Pilot Study", 
        "overall_official": {
            "affiliation": "University of Southern California", 
            "last_name": "Jacques Van Dam", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Exact binomial probabilities will be used.", 
                "measure": "Accurate classifications of women with or without breast cancer", 
                "safety_issue": "No", 
                "time_frame": "Up to 1 year"
            }, 
            {
                "description": "Multivariate analyses will be used.", 
                "measure": "Utility of optical markers in distinguishing cancer involved breasts from normal breasts", 
                "safety_issue": "No", 
                "time_frame": "Up to 1 year"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01755208"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Southern California", 
        "sponsors": {
            "collaborator": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "University of Southern California", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}